Process for the preparation of (3R, 3aS, 6aR)-hexahydrofuro [2, 3-b] furan-3-ol
The present invention relates to a novel process for the preparation of (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-ol of formula I by reacting a compound of formula VII with the compound of formula R2-OH in the presence of haloginating agent to obtain a compound of formula VI and treating a compound of formula VI with dehaloginating agent to obtain a compound of formula V by reducing a compound of formula V, followed by cylization to obtain compound of formula IV and separating the enantiomer and diastereomers from compound of formula IV to yield a compound of formula I. Compound of formula I is useful as an intermediate in the preparation of protease inhibitors, in particular broad spectrum HIV protease inhibitors, the present invention also relates to process for the preparation of Darunavir from (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-ol.
1. A process for the preparation of hexahydrofuro[2,3-b]furan-3-ol of formula I,
comprising the steps of:
a. reacting a compound of formula VII with a compound of formula R2-OH in the presence of a haloginating agent to obtain a compound of formula VI;
b. treating the compound of formula VI with a dehaloginating agent to obtain a compound of formula V;
c. reducing the compound of formula V, followed by cyclization to obtain hexahydrofuro[2,3-b]furan-3-ol of formula IV; and
d. separating enantiomers and diastereomers of the compound of formula IV to obtain the compound of formula I.
2. A process for the preparation of hexahydrofuro[2,3-b]furan-3-ol of formula I
comprising the steps of:
a. reacting a compound of formula VII with a compound of formula R 2 —OH optionally in the presence of an acid to obtain a compound of formula V;
b. reducing the compound of formula V, followed by cyclization to obtain hexahydrofuro[2,3-b]furan-3-ol of formula IV; and
c. separating enantiomers and diastereomers of the compound of formula IV to obtain the compound of formula I.
3. The process according to claim 1 or 2 , wherein the step of separating the enantiomers and diasteromers of the compound of formula IV to obtain the compound of formula I is carried out via an enzymatic or a chemical process.
4. A process for the preparation of (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-ol of formula I
from a compound of formula IV,
comprising the steps of:
a. reacting hexahydrofuro[2,3-b]furan-3-ol of formula IV with an acylating agent in the presence of a base, in a solvent, and optionally in the presence of a catalyst to obtain hexahydrofuro[2,3-b]furan-3-yl acetate of formula III;
b. hydrolyzing the hexahydrofuro[2,3-b]furan-3-yl acetate of formula III by employing an enzyme to obtain a mixture of the compounds of formula II and II′; and
c. hydrolyzing the enantiomer (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl acetate of formula II in the presence of a base in a solvent to obtain (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-ol of formula I.
5. The process according to claim 4 , wherein the catalyst used in step a) is N,N-dimethylamino pyridine.
6. A compound of formula V
wherein R 1 is C 1 -C 4 -alkyl and R 2 is C 1 -C 4 -alkyl or aryl.
7. A compound of formula VI
wherein R 1 is C 1 -C 4 -alkyl and R 2 is C 1 -C 4 -alkyl or Aryl and X is CI, Br, or I.
8. A process for preparation of substantially free diastereomers of a compound of formula IV, comprising the steps of:
a. oxidizing a mixture of enantiomers and diastereomers of a compound of formula IV containing the diastereomeric compounds of formula IVc and IVd
to obtain a keto compound of formula IV′; and
b. reducing the keto compound of formula IV′ to obtain substantially free diastereomers of the compound of formula IV,
whereby the mixture comprising the compound represented by formula IV is obtained by
c. reacting a compound of formula VII
with a compound of formula R 2 —OH in the presence of a haloginating agent to obtain a compound of formula VI;
d. treating the compound of formula VI with a dehaloginating agent to obtain a compound of formula V; and
e. reducing the compound of formula V, followed by cyclization to obtain hexahydrofuro[2,3-b]furan-3-ol of formula IV
9. The process according to claim 8 further comprising resolving or separating the enantiomers of the compound of formula IV to obtain the compound of formula I.